Products in Development

NeuroDerm’s pipeline includes dermally administered drugs for the treatment of Parkinson’s disease, Alzheimer’s disease and other common CNS diseases that should herald breakthroughs in the treatment of these diseases:

  • ND0612, a proprietary formulation of levodopa & carbidopa for continuous subcutaneous delivery through a custom patch pump, for the treatment of Parkinson’s disease. It enables for the first time to conveniently achieve steady state levodopa plasma levels.
  • ND0801-A, a patch for the treatment of cognition and attention deficits in various CNS diseases and disorders including ADHD, Alzheimer’s disease, Parkinson’s disease and Schizophrenia.



Terms of Use & Privacy Policy Copyright NeuroDerm © 2013 All rights reserved.